Tags : Precision Medicines


Vertex and Genomics plc forms a three-year collaboration extendable up

Shots: This collaboration plans to use human genetics and machine learning to address unmet needs by developing precision medicines Vertex will make £25M series B funding in Genomics (£10.5M equity investment) in addition to milestone and royalty payments from clinical developments to Genomics Genomics with its largest unique analysis engine having 100B data points linking […]Read More